MELBOURNE BIOTECH · 89-08 · AUSTRALIA

For MELBOURNE BIOTECH, import alert is 89-08; country is AUSTRALIA; import alert name is "Detention Without Physical Examination of Devices without Approved PMA's or IDE's and Other Devices Not Substantially Equivalent or Without a 510(k)"; product is MB COVID-19 Antibody Rapid Detection Test | MB COVID-19 Antibody Rapid Detection Test | MB COVID-19 Antibody Rapid Detection Test | MB COVID-19 Antibody Rapid Detection Test; product code is 83 Q - - JR Reagents, 2019-novel coronavirus nucleic acid | 83 Q - - KO Reagent, coronavirus serological | 83 Q - - KP Coronavirus antigen detection test system. | 83 Q - - LT COVID-19 multi-analyte respiratory panel nucleic acid devices; date published is 10/20/2020; address is 5505 35 Queens Bridge Street , Southbank, Victoria AUSTRALIA, verified against its source on 2026-09-30.

What the source says

MELBOURNE BIOTECH Date Published : 10/20/2020 5505 35 Queens Bridge Street , Southbank, Victoria AUSTRALIA

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

— all from accessdata.fda.gov, retrieved 2026-09-15

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_244.html

Last verified against source: 2026-09-30. Due for re-check by 2026-11-29. This page as Markdown · OKF bundle · full dataset as JSON.